| Product Name |
CAS No. |
Usage |
| S-2-Benzothiazolyl (Z) -2-(2-aminothiazol-4-yl)-2-acetyloxyiminothioacetate (CAEM) |
104797-47-9 |
Intermediate of Cefdinir [91832-40-5] |
| (2S,3S)-3-amino-2-methyl-4-oxo-1-azetidinesulfonic acid |
80082-65-1 |
Intermediate of Aztreonam [78110-38-0] |
| (Benzothiazol-2-yl)-(Z)-2-Methoxyimino-2-(2-Amino-thiozol-4-yl)Thioacetate (MAEM) |
80756-85-0 |
Intermediate of Ceftriaxone Sodium [104376-79-6] [74578-69-1] and Cefotaxime [63527-52-6], Cefotaxime Sodium [64485-93-4] |
| (Benzothiazol-2-yl)-(Z)-2-Trityimino-2-(2-Aminothiazol-4-yl)Thioac etate |
143183-03-3 |
Intermediate of Cefdinir [91832-40-5] |
| (R) -2-[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonylamino]-2-(4-hydroxyphenyl)acetic acid (OH-EPCP) |
62893-24-7 |
Intermediate of Cefoperazone [62893-19-0] and cefoperazone sodium [62893-20-3] |
| (Z) -4-Chloro-2-methoxyimino-3-oxobutanoic acid (CMOA) |
111230-59-2 |
Intermediate of Ceftriaxone Sodium [104376-79-6] [74578-69-1], Cefotaxime [63527-52-6], Cefotaxime Sodium [64485-93-4] And Cefodizime [69739-16-8], Cefodizime Sodium [86329-79-5] |
| (Z)-2-(2-Aminothiazol-4-yl)-2-(l-Carboxy-l-Methyl)Ethoxyimino Acetic Acid (ATCA) |
102507-85-7 |
Intermediate of Ceftazidime [78439-06-2] |
| (Z)-2-(2-Aminothiazol-4-yl)-2-(t-Butoxycarbonylmethoxyimino)Acetic Acid (ATTMA) |
74440-02-1 |
Intermediate of Cefixime [79350-37-1] and Carumonam [87638-04-8] |
| (Z)-2-(2-aminothiazol-4-yl)-2-acetyloxyiminoacetic acid (ATAIA) |
110130-88-6 |
Intermediate of cefdinir [91832-40-5] |
| (Z)-2-(2-Aminothiazol-4-yl)-2-Carboxymethoxyimino Acetic Acid (ATCMA) |
74440-05-4 |
Intermediate of Cefixime [79350-37-1] and Carumonam [87638-04-8] |
| (Z)-2-(2-Aminothiazol-4-yl)-2-methoxycarbonylmethoxyiminoacetic acid (MICA) |
80544-17-8 |
Intermediate of cefixime [79350-37-1] and carumonam [87638-04-8] |
| (Z)-2-(2-aminothiazol-4-yl)-2-pentenoic acid (ATPA) |
118109-49-2 |
Intermediate of cefcapene pivoxil hydrochloride [147816-24-8] and cefcapene pivoxil [105889-45-0] |
| (Z)-2-(2-Aminothiazol-4-yl)-2-Trityloxyimino Acetic Acid (ATOA) |
128438-01-7 |
Intermediate of Cefdinir [91832-40-5] |
| (Z)-2-(2-Formylaminothiazol-4-yl)-2-Methoxyimino Acetic Acid (FTMA) |
65872-43-7 |
Intermediate of Ceftriaxone Sodium [104376-79-6] [74578-69-1] and Cefotaxime [63527-52-6], Cefotaxime Sodium [64485-93-4] |
| (Z)-2-(2--t-Butoxycarbonylaminothiazol-4-yl)-2-Pentenoic Acid (BTPA) |
86978-24-7 |
Intermediate of Cefcapene pivoxil hydrochloride [147816-24-8] and Cefcapene pivoxil [105889-45-0] |
| (Z)-2-(2-tert-Butoxycarbonylprop-2-Oxyimino)-2-(2-Amino-thiazol-4-yl)Acetic Acid (AT-TBA) |
86299-47-0 |
Intermediate of Ceftazidime [78439-06-2] and Aztreonam [78110-38-0] |
| (Z)-2-(2-Tritylaminothiazol-4-yl)-2-Methoxyimino Acetic Acid (TTMA) |
64485-90-1 |
Intermediate of Ceftriaxone Sodium [104376-79-6] [74578-69-1] and Cefotaxime [63527-52-6], Cefotaxime Sodium [64485-93-4] |
| (Z)-2-(2-Tritylaminothiazol-4-yl)-2-trityloxyiminoacetic acid (TTOA) |
68786-47-0 |
Intermediate of cefdinir [91832-40-5] |
| (Z)-2-(5-Amino-1,2,4-Thiadiazol-3-yl)-2-Methoxyimino Acetic Acid (ATDA) |
72217-12-0 |
Intermediate of Cefozopran [113359-04-9] and Cefozopran hydrochloride [113981-44-5] |
| (Z)-2-(Methoxycarbonyl Methoxyimino)-2-(2-Aminothiazol-4-yl)Acetic Acid (MICA) |
80554-17-8 |
Intermediate of Cefixime [79350-37-1] |
| (Z)-2-(tert-Butoxycarbonylprop-2-Oxyimino)-2-(2-Tritylamino-thiazol-4-yl)Acetic Acid (TB-TAA) |
68672-66-2 |
Intermediate of Ceftazidime [78439-06-2] |
| (Z)-2-Hydroxyimino-2-(2-Aminothiazol-4-yl)Acetic Acid (HATA) |
66338-96-3 |
Intermediate of Cefdinir [91832-40-5], Ceftazidime [78439-06-2] and Cefotaxime [63527-52-6], Cefotaxime Sodium [64485-93-4] |
| (Z)-2-Methoxyimino-2-(2-Aminothiazol-4-yl)Acetic Acid Anhydrous (AMAA) |
65872-41-5 |
Intermediate of Ceftriaxone Sodium [104376-79-6] [74578-69-1] and Cefotaxime [63527-52-6], Cefotaxime Sodium [64485-93-4] |
| (Z)-2-Methoxyimino-2-(Furyl-2-yl)Acetic Ammonium Salt (SMIA) |
97148-39-5 |
Intermediate of Cefuroxime [55268-75-2] and Cefuroxime Sodium [56238-63-2] |
| 1-Methyl-5-Mercapto-1,2,3,4-Tetrazole (MMTZ) |
13183-79-4 |
Intermediate of Cefamandole [34444-01-4], Cefamandole Sodium [30034-03-8] and Cefoperazone [62893-19-0], Cefoperazone Sodium [62893-20-3] |
| 2-(2-Aminothiazol-4-yl)Acetic Acid (ATAA) |
29676-71-9 |
Intermediate of Cefotiam [61622-34-2] and Cefotiam Hydrochloride [66309-69-1] |
| 2-(2-Aminothiazol-4-yl)Acetic Acid Hydrochloride (ATAH) |
66659-20-9 |
Intermediate of Cefotiam [61622-34-2] and Cefotiam Hydrochloride [66309-69-1] |
| 2-(2-Aminothiazol-4-yl)Glyoxylic Acid (ATGA) |
73150-67-1 |
Intermediate of Cephalothins |
| 2-(2-Formylaminothiazol-4-yl)Acetic Acid (FTAA) |
75890-68-5 |
Intermediate of Cefotiam [61622-34-2] and Cefotiam Hydrochloride [66309-69-1] |
| 2-(2-Formylaminothiazol-4-yl)Glyoxylic Acid (FTGA) |
64987-06-0 |
Intermediate of Cephalothins |
| 2,5-Dihydro-6-Hydroxy-3-Mercapto-2-Methyl-5-Oxo-1,2,4-Triazine (TTZ) |
58909-39-0 |
Intermediate of Ceftriaxone Sodium [104376-79-6] [74578-69-1] |
| 205307-52-4 |
O,O-Diethylphosphoryl (Z)-2-(2-aminothiazol-4-yl)-2-acetyloxyiminoacetate (PAIA) |
Intermediate of Cefdinir [91832-40-5] |
| 2-Aminooxy-2-Methylpropanoic Acid Hydrochloride (AOIBA) |
89766-91-6 |
Intermediate of Ceftazidime [78439-06-2] and Aztreonam [78110-38-0] |
| 2-Mercapto-1,3,4-Thiadiazol (MTD) |
18686-82-3 |
Intermediate of Ceftezole [26973-24-0] and Ceftezole Sodium [41136-22-5] |
| 2-Mercapto-4-Methyl-5-Thiazoleacetic Acid (MMTA) |
34272-64-5 |
Intermediate of Cefodizime [69739-16-8] and Cefodizime sodium [86329-79-5] |
| 2-Mercapto-5-methyl-1,3,4-thiadiazole (MMTD) |
29490-19-5 |
Intermediate of Cefazolin [25953-19-9] and Cefazolin Sodium [27164-46-1] |
| 3-Hydroxy-5-Mercapto-4-Isothiazolecarboxylic Acid Monosodium Salt (HMIM) |
475112-25-5 |
Intermediate of Cefotetan [69712-56-7] and Cefotetan Disodium [74356-00-6] |
| 3-Hydroxy-5-mercapto-4-isothiazolecarboxylic acid trisodium salt (HMIT) |
76857-14-2 |
Intermediate of Cefotetan [69712-56-7] and Cefotetan Disodium [74356-00-6] |
| 3-thienylpropanedioic acid (TPA) |
21080-92-2 |
Intermediate of Ticarcillin [34787-01-4] and Ticarcillin Sodium [4697-14-7] |
| 4-Chioro-2-(Z)-Methoxycarbonyl Methoxyimino-3-Oxobutyric Acid (CMOBA) |
95759-10-7 |
Intermediate of Cefixime [79350-37-1] |
| 5-Mercapto-1,2,3,4-Tetrazole-1-Methyl Sulfonic Acid Di-sodium Salts (SMT-DS) |
66242-82-8 |
Intermediate of Cefonicid [61270-58-4] Cefonicid Sodium [61270-78-8] |
| 7-ANCA |
36923-17-8 |
Intermediate of Cephalothins |
| 7-AVCA |
79349-82-9 |
Intermediate of Cephalothins |
| 7-MAC |
56610-72-1 |
Intermediate of Cephalothins |
| Benzothiazol-2-yl-(Z)-2-(tert-Butoxycarbonylprop-2-Oxyimino)-(2-Aminothiazol-4-yl)Thioacetate (BPTA) |
89604-92-2 |
Intermediate of Ceftazidime [78439-06-2] |
| Ethyl 2-(2-Aminothiazol-4-yl)Acetate (EATA) |
53266-94-7 |
Intermediate of Cefotiam [61622-34-2] and Cefotiam Hydrochloride [66309-69-1] |
| Ethyl 2-(2-formylaminothiazol-4-yl) acetate (EFTA) |
64987-05-9 |
Intermediate of cefotiam [61622-34-2] and cefotiam hydrochloride [66309-69-1] |
| Ethyl(Z)-2-(2-Aminothiazol-4-yl)-2-(l-t-Butoxycarbonyl-l-Methyl)Ethoxyimino Acetate (EATB) |
86299-46-9 |
Intermediate of Ceftazidime [78439-06-2] and Aztreonam [78110-38-0] |
| Ethyl(Z)-2-(2-Aminothiazol-4-yl)-2-Methoxyiminoacetate (EATM) |
64485-88-7 |
Intermediate of Ceftriaxone Sodium [104376-79-6] [74578-69-1], Cefotaxime [63527-52-6], Cefotaxime Sodium [64485-93-4] and Cefodizime [69739-16-8], Cefodizime sodium [86329-79-5] |
| Ethyl(Z)-2-Hydroxyimino-2-(2-Aminothiazol-4-yl)Acetate (EHATA) |
64485-82-1 |
Intermediate of Cefdinir [91832-40-5] and Ceftazidime [78439-06-2] |
| Ethyl-2-(2-Aminothiazol-4-yl)-2-Oxo-Acetate (EAOA) |
64987-08-2 |
Intermediate of Cephalothins |
| Ethyl-2-(2-Formylaminothiazol-4-yl)Glyoxylate (EFTG) |
64987-03-7 |
Intermediate of Cephalothins |
| L-(-)-¦Á-Hydroxy-¦Ã-Amino Butyric Acid (HABA) |
40371-51-5 |
Intermediate of Amikacin [37517-28-5] and Amikacin Sulfate [39831-55-5] |
| L-(-)-¦Á-Hydroxy-¦Ã-Benzyloxycarbonylamino Butyric Acid (CBZ-HABA) |
40371-50-4 |
Amikacin [37517-28-5] and Amikacin Sulfate [39831-55-5] |
| O,O-Diethylphosphoryl (Z)-2-(2-aminothiazol-4-yl)-2-(1-t-butoxycarbonyl-1-methyl) ethoxyiminoacetate (PABA) |
179258-52-7 |
Intermediate of Ceftazidime [78439-06-2] and Aztreonam [78110-38-0] |
| O,O-Diethylphosphoryl (Z)-2-(2-aminothiazol-4-yl)-2-(t-butoxycarbonylmethoxyimino) acetate (PTMA) |
204185-34-2 |
Intermediate of Cefixime [79350-37-1] and Carumonam [87638-04-8] |
| O,O-Diethylphosphoryl (Z)-2-(2-aminothiazol-4-yl)-2-methoxycarbonylmethoxyiminoace-tate (PMMA) |
C12H18N3O8PS |
Intermediate of Cefixime [79350-37-1] and Carumonam [87638-04-8] |
| O,O-Diethylphosphoryl (Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetate (PAMA) |
179258-53-8 |
Intermediate of Ceftriaxone Sodium [104376-79-6] [74578-69-1] and Cefotaxime [63527-52-6], Cefotaxime Sodium [64485-93-4] |
| O,O-Diethylphosphoryl (Z)-2-(2-aminothiazol-4-yl)-2-trityloxyiminoacetate (PAOA) |
193402-47-0 |
Intermediate of Cefdinir [91832-40-5] |
| O,O-Diethylphosphoryl (Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetate (PATD) |
C9H15N4O6PS |
Intermediate of Cefozopran [113359-04-9] and Cefozopran Hydrochloride [113981-44-5] |
| O,O-Diethylthiophosphoryl (Z) -2-(2-aminothiazol-4-yl)-2-(t-butoxycarbonylmethoxyimino) acetate (DTMA) |
524925-11-9 |
Intermediate of Cefixime [79350-37-1] and Carumonam [87638-04-8] |
| O,O-Diethylthiophosphoryl (Z) -2-(2-aminothiazol-4-yl)-2-acetyloxyiminoacetate (DAIA) |
200815-01-6 |
Intermediate of Cefdinir [91832-40-5] |
| O,O-Diethylthiophosphoryl (Z) -2-(2-aminothiazol-4-yl)-2-methoxycarbonylmethoxyi-minoacetate (DMMA) |
C18H12N3O7PS2 |
Intermediate of Cefixime [79350-37-1] and Carumonam [87638-04-8] |
| O,O-Diethylthiophosphoryl (Z) -2-(2-aminothiazol-4-yl)-2-trityloxyiminoacetate (DAOA) |
200814-98-8 |
Intermediate of Cefdinir [91832-40-5] |
| O,O-Diethylthiophosphoryl (Z)- 2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyimino acetate (DATD) |
C9H15N4O5PS2 |
Intermediate of Cefozopran [113359-04-9] |
| O,O-Diethylthiophosphoryl(Z)-2-(2-Aminothiazol-4-yl)-2-(l-t-Butoxycarbonyl-l-Methyl)Ethoxyiminoacetate (DABA) |
162208-28-8 |
Intermediate of Ceftazidime [78439-06-2] and Aztreonam [78110-38-0] |
| S-2-Benzothiazolyl (Z)-2-(2-aminothiazol-4-yl)-2-(t-butoxycarbonylmethoxyimino) thioacetate (DAEM) |
89605-09-4 |
Intermediate of Cefixime [79350-37-1] and Carumonam [87638-04-8] |
| S-2-Benzothiazolyl (Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyimino thioacetate (ZAEM) |
89604-91-1 |
Intermediate of Cefozopran [113359-04-9] and Cefozopran hydrochloride [113981-44-5] |
| S-2-Benzothiazolyl(Z)-2-(2-Aminothiazol-4-yl)-2-Methoxycarbonylmethoxyiminothioacetate (FAEM) |
246035-38-1 |
Intermediate of Cefixime [79350-37-1] and Carumonam [87638-04-8] |
